Prototype build • offline demo cards • source-safe architecture

A disease-first watchtower for translational science.

This build organizes a 132-indication watchlist into a searchable product shell that prioritizes basic science, preclinical animal-model work, and phase 1 / phase 2 studies. It is designed to use source-approved APIs and metadata feeds first, while treating higher-risk properties like Google Scholar as link-out surfaces rather than scrape targets.

Every manuscript card is badged as basic science, preclinical, early clinical, or combo, then graded using citations, journal signal, and first / second / last author h-indices.

Legal-by-design choices

Metadata-first indexing, original in-house digests, no PDF mirroring, no figure reuse, no automated Scholar scraping, and OA-only full-text mining where license terms allow.

What is included in this artifact

A polished static prototype, the full 132-indication seed, demo headline cards, query bundles, an admin dashboard placeholder, and a compliance architecture you can hand to engineering.

🩺 Indications
132
Watchlist seeded from your indication brief
Territories
7
Named territories in this seed file
Refresh cadence
Every 6 hours
Planned cron schedule for live ingestion
Copyright posture
Metadata-first
Link-out heavy • no PDF/figure mirroring

Named territories in seed data: 7. Source brief references 8 territories.

Indication library

Browse the seed list by disease. Click any indication to load its feed and query bundle.

132 visible

Cardiology

Signal tracking for vascular, rhythm, heart failure, and cardiometabolic mechanisms with a bias toward foundational biology and early translational work.

11

Endocrinology

A disease-first monitor for hormone biology, metabolic signaling, and early intervention studies.

10

Gastroenterology

Digestive, hepatobiliary, intestinal, and infection-adjacent indications with mechanistic and translational emphasis.

11

Hematology

Coagulation, thrombosis, and platelet disorders with special attention to rare disease biology and first-in-human signals.

8

Immunology

Immune-mediated disease surveillance spanning inflammatory pathways, barrier tissues, and autoimmune clinical proof-of-concept.

19

Neurology

Neurodegeneration, psychiatry-adjacent CNS disease, sleep, seizure, and neuromuscular science with biomarker and early-phase focus.

17

Oncology

Tumor-type-specific intake for mechanism, model, translational biomarker, and phase 1 / phase 2 oncology readouts.

56

Compliance

Copyright and platform-risk guardrails

This design is optimized to reduce infringement and terms-of-service risk while still creating a useful disease-centric literature intelligence product.

1. Collect only what you can lawfully collect

Use API / RSS / allowed bulk services for PubMed, Europe PMC, bioRxiv, medRxiv, Crossref, and OpenAlex.

2. Store minimal content

Keep IDs, titles, author metadata, dates, badges, citations, journal metrics, and our own digested headlines.

3. Link out for reading

Send users back to the source record or publisher page instead of hosting the article PDF or publisher layout.

Report a problem or request takedown